Why 90% of clinical drug development fails and how to improve it?

Sun, Duxin, Gao, Wei, Hu, Hongxiang, Zhou, Simon·2022·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2022.02.002

Cited by (1,000)

Items 501–600 of 1,000

  1. Improving Ex Vivo Nasal Mucosa Experimental Design for Drug Permeability Assessments: Correcting Mucosal Thickness Interference and Reevaluating Fluorescein Sodium as an Integrity Marker for Chemically Induced Mucosal Injury
    Sheng Zhao, Jieyu Zuo, Marlon C. Mallillin, Ruikun Tang, Michael R. Doschak, Neal M. Davies, Raimar Löbenberg · 2025 · Pharmaceuticals
  2. Advancing active compound discovery for novel drug targets: insights from AI-driven approaches
    Xing-You Wang, Yang Chen, Yu-fan Li, Chaoyang Wei, Meng-Ya Liu, Chen-Xing Yuan, Yao-yu Zheng, Mo-han Qin, Yu-feng Sheng, Xiaochu Tong et al. · 2025 · Acta Pharmacologica Sinica
  3. Enhancing Drug-Target Interaction Prediction through Transfer Learning from Activity Cliff Prediction Tasks
    Regina R. Ibragimova, Dimitrios Iliadis, Willem Waegeman · 2025 · Journal of Chemical Information and Modeling
  4. Epigenetics Plays a Role in the Pathogenesis and Treatment of Diabetes
    Kajetan Kiełbowski, Estera Bakinowska, Andrzej Pawlik · 2025 · Genes
  5. MMPK: A Multimodal Deep Learning Framework to Predict Human Oral Pharmacokinetic Parameters
    Xiang Li, Meiling Zhan, Jiaojiao Fang, Guixia Liu, Yun Tang, Weihua Li · 2025 · Journal of Medicinal Chemistry
  6. Multi-targeted azacoumarin–cyanocinnamate hybrids induce G 2 /M arrest and apoptosis via tubulin, and COX-2/VEGFR modulation: insights from in vitro mechanistic basis and in vivo validation
    Manar A. El-Zend, Ibrahim M. El‐Deen, Rawda M Mansour, Tarek A. Yousef, Amal Abdullah Alrashidi, Essa M. Saied · 2025 · RSC Medicinal Chemistry
  7. Beyond preservation: future machine perfusion for liver assessment and repair
    Florian Huwyler, Jonas Binz, Leslie Cunningham, Matthias Pfister, Martin J. Schuler, Mark W. Tibbitt, Pierre‐Alain Clavien · 2025 · Nature Reviews Gastroenterology & Hepatology
  8. Disruptions in bioactivity driven by dose: a challenge for drug discovery
    David Ignacio Ramírez‐Palma, Karina Martínez‐Mayorga · 2025 · Drug Discovery Today
  9. Bioactive compounds from marine algae in pancreatic cancer therapy: mechanistic insights into fucoidan and phlorotannins: a review
    N. Prabhu, Venkatesan Rajinikanth, Mathiyazhagan Narayanan · 2025 · Medical Oncology
  10. Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans
    Emily G. Gracey, Jed Noah Lampe · 2025 · Drug Metabolism and Disposition
  11. Crystal engineering considerations for pharmaceutical co-crystals
    Summaya Khazir, Abdul Haseeb Shah, Jose V. Parambil, Aijaz A. Dar · 2025 · CrystEngComm
  12. UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
    Jake Silberg, Kyle Swanson, Elana P. Simon, Angela Zhang, Zaniar Ghazizadeh, Scott Ogden, Hisham K. Hamadeh, James Zou · 2024 · neural information processing systems
  13. Intelligence on the graph: Graph neural networks for mechanistic drug target discovery
    Jing Chen, Nini Fan, Yuqing Lu, Jianhua Yang, Wenchao Song, Haiyang Sheng, Yinfeng Yang, Sirui Chen, Jinghui Wang · 2025 · Journal of Pharmaceutical Analysis
  14. My cells, my model: immune-competent autologous organ-on-chip systems as a new paradigm in precision medicine
    Francesco Bisconti, Hugo Abreu, Thuy Duong Nguyen, Fabiola Stolfi, Noemi Corbezzolo, Giuseppe Gigli, Davide Raineri, Giuseppe Cappellano, Alessandro Polini, Francesca Gervaso et al. · 2025 · Frontiers in Immunology
  15. Proteolysis Targeting Chimera Loaded Extracellular Vesicles for Developing Triple Negative Breast Cancer Treatment
    Nina Erwin, Umasankar De, Yufeng Xiao, Lei Wang, Chandra K. Maharjan, Xiaoshu Pan, Ding Zuo, Nikee Awasthee, Guangrong Zheng, Daiqing Liao et al. · 2025 · Journal of Extracellular Vesicles
  16. Simple and Efficient Synthesis of 3-Aryl-2-oxazolidinone Scaffolds Enabling Increased Potency toward Biofilms
    Audrey R. N. Ndukwe, Sophia Hawas, Jilong Qin, Sandra Wiedbrauk, Makrina Totsika, Nathan R. B. Boase, Kathryn E. Fairfull‐Smith · 2023 · Molecular Pharmaceutics
  17. Integrating Transcriptomic and Structural Insights: Revealing Drug Repurposing Opportunities for Sporadic ALS
    Naina Sunildutt, Faheem Ahmed, Abdul Rahim Chethikkattuveli Salih, Jong‐Hwan Lim, Kyung Hyun Choi · 2024 · ACS Omega
  18. Site-specific thrombus formation: advancements in photothrombosis-on-a-chip technology
    Kuan-Ting Liu, Pai-Wen Wang, Han‐Yun Hsieh, Han-Chi Pan, Hsian-Jean Genie Chin, Che-Wei Lin, Yu-Jen Huang, Yung-Chieh Liao, Ya-Chun Tsai, Shang-Ru Liu et al. · 2024 · Lab on a Chip
  19. Drug-delivery and biological activity in colorectal cancer of a supramolecular porous material assembled from heptameric chromium-copper-adenine entities
    Sandra Mena-Gutiérrez, Ekain Maiza-Razkin, Jon Pascual-Colino, Marcos Jesus Araúzo-Bravo, Garikoitz Beobide, Óscar Castillo, Ainara Castellanos–Rubio, Daniela Gerovska D, Antonio Luque, Sonia Pérez‐Yáñez · 2024 · Journal of Materials Chemistry B
  20. Computer-aided technologies in drug discovery and toxicity prediction
    Bhakti Pawar, Santosh Kumar Behera, Muktika Tekade, Nizar A. Al‐Shar’i, Rakesh Kumar Tekade · 2023 · Elsevier eBooks
  21. Clinical trials of probiotics: Current outlook
    Haitham Al‐Madhagi, Abir Alramo · 2023 · Food Science & Nutrition
  22. Integrative network analysis suggests prioritised drugs for atopic dermatitis
    Antonio Federico, Lena Möbus, Zeyad Al-Abdulraheem, Alisa Pavel, Vittorio Fortino, Giusy del Giudice, Harri Tapio Alenius, Nanna Fyhrquist, Dario Greco · 2024 · Journal of Translational Medicine
  23. Involvement of Extracellular Vesicles in the Proinflammatory Response to Clozapine: Implications for Clozapine-Induced Agranulocytosis
    Samantha Christine Sernoskie, Éric Bonneil, Pierre Thibault, Alison Jee, Jack Uetrecht · 2024 · Journal of Pharmacology and Experimental Therapeutics
  24. Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
    Hélène Lê, Jules Deforges, Pasquale Cutolo, Anissa Lamarque, Guoqiang Hua, Véronique Lindner, Shreyansh Jain, Jean‐Marc Balloul, Nadia Benkirane-Jessel, Éric Quéméneur · 2024 · Frontiers in Immunology
  25. Synthesis of 2‐Substituted Bicyclo[2.1.1]Hexan‐1‐ols via SmI2‐Mediated Reductive Cyclization Reactions
    Chih‐Wei Hsu, Chunfu Wu, Yung‐Chi Lee, Woo‐Jin Yoo · 2024 · Advanced Synthesis & Catalysis
  26. Induced Extracellular Ice Nucleation Protects Cocultured Spheroid Interior and Exterior during Cryopreservation
    Yanan Gao, Akalabya Bissoyi, Qiongyu Guo, Matthew I. Gibson · 2024 · ACS Biomaterials Science & Engineering
  27. Stroke of Consistency: Streamlining Multicenter Protocols for Enhanced Reproducibility of Infarct Volumes in Preclinical Stroke Research
    Gemma Llovera, Friederike Langhauser, Sara Isla Cainzos, Maike Hoppen, Hanna Abberger, Ayan Mohamud Yusuf, Stine Mencl, Steffanie Heindl, Alessio Ricci, Steffen Haupeltshofer et al. · 2024 · Stroke
  28. Integrating text mining with network models for successful target identification: in vitro validation in MASH-induced liver fibrosis
    Jennifer Venhorst, Roeland Hanemaaijer, Remon Dulos, Martien P. M. Caspers, Karin H. Toet, Joline Attema, Christa de Ruiter, Gino J. Kalkman, Tanja Rouhani Rankouhi, Jelle C. B. C. de Jong et al. · 2024 · Frontiers in Pharmacology
  29. Promising Phytoconstituents in Antiangiogenesis Drug Development
    Ibrahim M. Abu‐Reidah, Amani Taamalli · 2024 · Nutraceuticals
  30. Predicting the effects of drugs and unveiling their mechanisms of action using an interpretable pharmacodynamic mechanism knowledge graph (IPM-KG)
    Tatsuya Tanaka, Toshiaki Katayama, Takeshi Imai · 2024 · Computers in Biology and Medicine
  31. Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies
    Vijay Hariram Masand, Meghshyam K. Patil, Sami A. Al‐Hussain, Abdul Samad, Vesna Rastija, Rahul D. Jawarkar, Gaurav S. Masand, Rakhi G. Gawali, Magdi E. A. Zaki · 2025 · Chemical Biology & Drug Design
  32. Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: in vitro biological and in silico pharmacokinetic assessments
    Waralee Ruankham, Ratchanok Pingaew, Veda Prachayasittikul, Apilak Worachartcheewan, Suphissara Sathuphong, Setthawut Apiraksattayakul, Tanawut Tantimongcolwat, Virapong Prachayasittikul, Supaluk Prachayasittikul, Kamonrat Phopin · 2025 · RSC Advances
  33. Refined ADME Profiles for ATC Drug Classes
    Luca Menestrina, Raquel Parrondo-Pizarro, Ismael Gómez, Ricard García-Serna, Scott K. Boyer, Jordi Mestres · 2025 · Pharmaceutics
  34. Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study
    Longgang Xiang, Ying Peng · 2025 · International Journal of Molecular Sciences
  35. Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
    Damian Kułaga, Anna Karolina Drabczyk, Przemysław Zaręba, Jolanta Jaśkowska, Grzegorz Satała, Paula Zaręba, Anna Więckowska, Modesto de Candia, Rosa Purgatorio, Anna Boguszewska‐Czubara et al. · 2025 · Biomedicine & Pharmacotherapy
  36. Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease
    Jihane Touhtouh, Fettouma Chraa, Doha EL Meskini, Taoufiq Benali, Abdelhakim Bouyahya, Long Chiau Ming, Said Moshawih, Khalil Hammani, Tarik Aanniz · 2025 · Results in Chemistry
  37. Real-Time SPR Biosensing to Detect and Characterize Fast Dissociation Rate Binding Interactions Missed by Endpoint Detection and Implications for Off-Target Toxicity Screening
    William Martelly, Rebecca L. Cook, Chidozie Victor Agu, Lydia R. Gushgari, Salvador Moreno, Sailaja Kesiraju, Mukilan Mohan, Bharath R. Takulapalli · 2025 · Biomolecules
  38. Out of control: Blinding, dose response, and psychosocial controls in psychedelic trials
    Sandeep Manel Nayak, Zarmeen Zahid · 2025 · Journal of Psychopharmacology
  39. Biased Allosteric Modulation in GPCR Drug Discovery
    Jingzhi-Christina Zhou, Minyong Li, Alan Long, Alem W. Kahsai · 2025 · Handbook of experimental pharmacology
  40. Deciphering molecular pathways driving cancer invasion and metastasis: advances and therapeutic prospects
    Aziza Alshahrani, Arwa Alsubait, Zahrah Ali Asiri, Sahar S. Alghamdi, Sarah Bin Saqyah, Tariq Alqahtani, Rawan Anwar Fitaihi, Njoud Altuwaijri, Yahya Fahad Jamous · 2025 · Frontiers in Oncology
  41. A cytokine receptor–targeting chimera toolbox for expanding extracellular targeted protein degradation
    Kaan S. Kumru, Zi W. Yao, Brandon B. Holmes, Fangzhu Zhao, Yun Zhang, Emilio Ferrara, Trenton M. Peters-Clarke, Kevin K. Leung, James A. Wells · 2026 · Proceedings of the National Academy of Sciences
  42. Evolution of human pharmacokinetics prediction methods: from allometry to artificial intelligence
    Nayoung Choi, Beom Soo Shin, Soyoung Shin · 2026 · Journal of Pharmaceutical Investigation
  43. Artificial intelligence-generated synthetic data for cancer research and clinical trials
    Jan‐Niklas Eckardt, Waldemar Hahn, Arsela Prelaj, Martin Bornhäuser, Jan Moritz Middeke, Jakob Nikolas Kather · 2026 · Nature reviews. Cancer
  44. AI in Drug Discovery: Clinical Failures, Regulatory Reality, and the Validation Crisis Behind the Hype
    Lisa Khairil, Koay Hean Seng Benny, Jesreena Jerry, Farhat Mussa Khatib, Muhammad Danial Che Ramli, Suresh Kumar · 2026 · Pharmaceuticals
  45. Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
    Sónia Pinho, Sandra Isabel Anjo, Teresa Cunha‐Oliveira · 2023 · Antioxidants
  46. Sulfated carboxymethylcellulose mediated enhancement of Timp3 efficacy synergistically attenuates osteoarthritis through inhibition of NFκB and JNK
    Arijit Bhattacharjee, Nihal Singh, Praganesh Kumar, Dhirendra S. Katti · 2023 · Carbohydrate Polymers
  47. Integrated data-driven and experimental approaches to accelerate lead optimization targeting SARS-CoV-2 main protease
    Rohith Anand Varikoti, Katherine Schultz, Chathuri Jeewanthi Kombala Nanayakkara Thambiliya, Agustin Kruel, Kristoffer R. Brandvold, Mowei Zhou, Neeraj Kumar · 2023 · Journal of Computer-Aided Molecular Design
  48. Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors
    Viola Noti, Eleni A. Pontiki, Dimitra Hadjipavlou‐Litina · 2023 · Molecules
  49. How Do Molecular Systems Engineering Scientists Frame the Ethics of Their Research?
    Renan Gonçalves Leonel da Silva, Alessandro Blasimme, Effy Vayena, Kelly E. Ormond · 2024 · AJOB Empirical Bioethics
  50. Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
    Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross · 2024 · Pharmaceuticals
  51. Discovery of novel CDK4/6 inhibitors from fungal secondary metabolites
    Abhijit Debnath, Rupa Mazumder, Rajesh Kumar Singh, Anil Kumar Singh · 2024 · International Journal of Biological Macromolecules
  52. Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
    Xiaodan Zhang, Tianhong Cheng, Hyun‐Jung Cho, Wenjia Lu, Delphine Denoyer, Paul J. McMillan, Kalyan Shobhana, Swati Varshney, Nicholas A. Williamson, Alastair G. Stewart · 2024 · Pharmacological Research
  53. Ionic liquid [FcMeBIMIoct] [Br−] catalyzed multicomponent synthesis, anticancer activity, in silico ADMET, DFT, QSAR and molecular docking studies of new dihydropyrimidine-thiones
    Ramdas Naiknaware, Ravi Ajudia, Hitesh Vekariya, Trupti Bansode, Gajanan S. Rashinkar, Prakash A. Bansode · 2025 · Journal of Molecular Liquids
  54. Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators
    Valentina Barcherini, Joana B. Loureiro, Ana Sena, Catarina Alexandra Catanas Madeira, Paula Leandro, Lucı́lia Saraiva, Alexandra M. M. Antunes, Maria M. M. Santos · 2023 · Pharmaceuticals
  55. FDA-approved drugs in 2022: A brief outline
    Haitham Al‐Madhagi · 2023 · Saudi Pharmaceutical Journal
  56. Tumor-on-a-Chip: Microfluidic Models of Hypoxic Tumor Microenvironment
    Arpana Parihar, Nishant Kumar Choudhary, Dipesh Singh Parihar, Raju Khan · 2023 · Springer eBooks
  57. Co-Delivery of Therapeutics and Bioactive Gas Using a Novel Liposomal Platform for Enhanced Treatment of Acute Arterial Injury
    Shaoling L. Huang, Melanie R. Moody, Xing Yin, David D. McPherson, Hyunggun Kim · 2023 · Biomolecules
  58. Advancements in Rational Multi‐Targeted Drug Discovery
    Balaguru Ravikumar, Anna Cichońska, Navriti Sahni, Tero A. Aittokallio, Rayees Rahman · 2024 · Polypharmacology
  59. A gastrointestinal locally activating Janus kinase inhibitor to treat ulcerative colitis
    Yingzi Bu, Mohamed Dit Mady Traore, Luchen Zhang, Lu Wang, Zhongwei Liu, Hongxiang Hu, Meilin Wang, Chengyi Li, Duxin Sun · 2023 · Journal of Biological Chemistry
  60. Antibiotic Development: Lessons from the Past and Future Opportunities
    Michael S. Kinch, Zachary Kraft, Tyler Schwartz · 2024 · Pharmaceutical Research
  61. Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models
    Carlos Franciney Moreira Vasconcelos, Agnieszka Zofia Neugebauer, Ricardo Basto Souza · 2024 · Basic & Clinical Pharmacology & Toxicology
  62. Sharing best practices for educational programs on venture creation and commercialization
    Jordan Eidlisz, Zachary Hill-Whilton, Gabriel Vizgan, Daniel Cobos, Sadhana Chitale, Colleen C. Gillespie, Nabil Dib, Gabrielle Gold‐von Simson · 2024 · Nature Biotechnology
  63. Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient
    Samantha J. Emery‐Corbin, Jumana M. Yousef, Subash Adhikari, Fransisca Sumardy, Duong Nhu, Mark F. van Delft, Guillaume Lessène, Jerzy Michal Dziekan, Andrew Ian Webb, Laura F. Dagley · 2024 · PROTEOMICS
  64. Levofloxacin reposition-based design: synthesis, biological evaluation of new levofloxacin derivatives targeting topoisomerase II beta polymerase as promising anticancer agents, molecular docking, and physicochemical characterization
    Zeinab Mahmoud, Mohamed Ismail, Mona Monir Kamel, Amira Youssef · 2024 · RSC Advances
  65. Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region
    Mohammed S. Alasmari, Salwa Albusaysi, Marwa Elsaeed Elhefnawy, Ali Mohamed Ali, Khalid Altigani, Mohammed Almoslem, Mohammed Alharbi, Jahad Alghamdi, Abdullah Alsultan · 2024 · Saudi Pharmaceutical Journal
  66. Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program
    Richa Madan Lomash, Jean Dehdashti, Oleg A. Shchelochkov, Randy J. Chandler, Lina Li, Irini Manoli, Jennifer L. Sloan, Pramod Terse, Xin Xu, Dimah N. Saade et al. · 2025 · Human Gene Therapy
  67. Bone-on-a-Chip Systems for Hematological Cancers
    Gül Kozalak, Ali Koşar · 2025 · Biosensors
  68. Unlocking the microbial treasure trove: advances in Streptomyces derived secondary metabolites in the battle against cancer
    Adrija Mukherjee, Ruma Sarkar · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  69. Daidzin Enhances the Anticonvulsion Effects of Carbamazepine and Diazepam, Possibly Through Voltage-Gated Sodium Channels and GABAA-Dependent Pathways
    Muhammad Torequl Islam, Md. Sakib Al Hasan, Jannatul Ferdous, S U Ahammed, Md. Shimul Bhuia, Salehin Sheikh, Noshin Tasnim Yana, Irfan Aamer Ansari, Siddique Akber Ansari, Md. Saifuzzaman · 2025 · Molecular Neurobiology
  70. Binding Interaction and Stability Analysis of Quercetin and its Derivatives as Potential Inhibitors of Triple Negative Breast Cancer (TNBC) against PARP1 Protein: An in-silico Study
    Md Alfaz Hossain, Fahmida Mariam Fariha, Md. Arju Hossain, Md Reduanul Haque Kavey, Md. Shamim, Md. Mobinul Hoque, Ali Mohamod Wasaf Hasan, Md. Ataur Rahman, Abdel Halim Harrath, Md Habibur Rahman · 2025 · Current Pharmaceutical Design
  71. Computational Hit Finding: An Industry Perspective
    Paraskevi Gkeka, Fredrik Svensson, Carlos Roca, Marcel John de Groot, Steven V. Jerome · 2025 · Journal of Medicinal Chemistry
  72. Synthesis, structural characterization, and antimicrobial activity of Zn(cloxyquin) 2 : towards harnessing zinc intoxication and immune response restoration to combat Staphylococcus aureus and Mycobacterium tuberculosis
    Khalil Mudarmah, Nalin Abeydeera, Guanyu Chen, Wjdan Jogadi, Jeanette A. Krause, Jonathan M. Budzik, Songping D. Huang · 2025 · Dalton Transactions
  73. Lung cancer intravasation-on-a-chip: Visualization and machine learning-assisted automatic quantification
    Christy Wing Tung Wong, Joyce Zhi Xuen Lee, Anna Jaeschke, Sammi Sze Ying Ng, Kwok Keung Lit, Ho-Ying Wan, Caroline Kniebs, Dai Fei Elmer Ker, Rocky S. Tuan, Anna Maria Blocki · 2025 · Bioactive Materials
  74. Nanoparticle-Mediated Gene Therapy in Women’s Health: Progress, Delivery Challenges, and the Need for Sex, Age, and Ancestry Informed Design
    Angelea Maestas-Olguin, Maya M. Dawson, Eunice Quartey, Peace Ikwuemesi, Olivia L. Lanier · 2025 · ACS Biomaterials Science & Engineering
  75. Breast cancer organoids: Advancements and applications in precision medicine.
    D. Leung, Jasveena Kaur, Gary Richardson, Thierry Jardé · 2025 · Critical reviews in oncology/hematology
  76. Variable expression of hepatic genes in different liver tumor cell lines: conclusions for drug testing
    Monika Joanna Wisniewska, Agnieszka Wencel, Malgorzata Jakubowska, Joanna Agata Motyl, Krzysztof D. Dudek, Beata Burzyńska, Dorota G. Pijanowska, Krzysztof Dariusz Pluta · 2025 · Frontiers in Cell and Developmental Biology
  77. Redefining Breast Cancer Care by Harnessing Computational Drug Repositioning
    Elena-Daniela Jurj, Daiana Colibăşanu, Sabina-Oana Vasii, Liana Suciu, Cristina Adriana Dehelean, Lucreția Udrescu · 2025 · Medicina
  78. Enhancing Large-Scale Pharmacogenetic Studies in African Populations for Clinical Care and Drug Development
    Abdoulaye Yalcouyé, Kevin Kum Esoh, Ambroise Wonkam · 2025 · The Annual Review of Pharmacology and Toxicology
  79. Factors of bias in spheroid-based drug screening: Fabrication method, spheroid size, and cell viability
    Sunghan Lee, Jiseok Lim, Bongseop Kwak · 2025 · Biomedicine & Pharmacotherapy
  80. Potential next generation targets for antibacterial agent's discovery and development
    Pooja Gupta, Pushplata Yadav, Manjul Lata, Shivani Chaudhary, Vrushti Telang, Raj Kishore, Jai Kishan, Kamini Goswami, Jesu Arockiaraj, L Ravithej Singh et al. · 2025 · European Journal of Medicinal Chemistry
  81. Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality
    Dominik Macak, Philipp Kanis, Stephan Riesenberg · 2025 · Nature Communications
  82. Multimodal out-of-distribution individual uncertainty quantification enhances binding affinity prediction for polypharmacology
    Amitesh Badkul, Li Xie, Shuo Zhang, Lei Xie · 2025 · Nature Machine Intelligence
  83. The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health
    Ricardo Scheufen Tieghi, Tracy Beth Høeg, Martin A. Makary, Nicole Kleinstreuer · 2025 · NEJM AI
  84. Redox responsive nanosystems for medicine: from reactive species mapping to precision treatment
    Rui Sang, Biyao Yang, Kainat Zahra, Fei Deng, Zi Gu, Ewa Magdalena Goldys, Wei Deng · 2026 · Advanced Drug Delivery Reviews
  85. Pharmacological Potential of Pyrmidine Derivatives: A Review With Emphasis on Antiviral Effects and Virtual Screening Against Sars‐Cov‐2 Molecular Targets
    Erick Costa, Zenaide Severina do Monte, Emerson P. S. Falcão, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Luciana Scotti, Marcus Tullius Scotti, Sebastiao Jose de Melo · 2023 · ChemistrySelect
  86. Microbial Metabolites of 3-n-butylphthalide as Monoamine Oxidase A Inhibitors
    Joanna Gach, Joanna Grzelczyk, Tomasz Strzała, Filip Boratyński, Teresa Olejniczak · 2023 · International Journal of Molecular Sciences
  87. Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
    Stevenson, Garrett A., Kirshner, Dan, Bennion, Brian J., Yang, Yue, Zhang, Xiaohua, Zemla, Adam, Torres, Marisa W., Epstein, Aidan, Jones, Derek, Kim, Hyojin et al. · 2023 · Journal of Chemical Information and Modeling
  88. Trends and Applications in Computationally Driven Drug Repurposing
    Luca Pinzi, Giulio Rastelli · 2023 · International Journal of Molecular Sciences
  89. Fragment databases from screened ligands for drug discovery (FDSL-DD)
    Jerica Wilson, Bahrad Ali Sokhansanj, Wei Chuen Chong, Rohan Chandraghatgi, GAIL L. ROSEN, Hai‐Feng Ji · 2023 · Journal of Molecular Graphics and Modelling
  90. In silico Pharmacokinetic and Toxicity Prediction of Compounds from Andrographis paniculata (Burm.f.) Nees.
    Izatunnafis Izatunnafis, Yosi Bayu Murti, Bambang Sulistyo Ari Sudarmanto · 2023 · Journal of Food and Pharmaceutical Sciences
  91. Identification of Novel CDK 4/6 Inhibitors by High-throughput Virtual Screening
    Abhijit Debnath, Rupa Mazumder · 2024 · Letters in Drug Design & Discovery
  92. Alzheimer’s disease and clinical trials
    Deepraj Paul, Rohini Agrawal, Swati Singh · 2024 · Journal of Basic and Clinical Physiology and Pharmacology
  93. Applying new approach methodologies to assess next-generation tobacco and nicotine products
    David Thorne, Damian McHugh, Liam Simms, K. Monica Lee, Hitoshi Fujimoto, Sara Moses, Marianna Gaça · 2024 · Frontiers in Toxicology
  94. What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate
    Francesca Pistollato, Gregor Burkhart, Pierre Deceuninck, Camilla Bernasconi, Sergio Di Virgilio, Luca Emili, Anne‐Charlotte Fauvel, L. Bastos, Annalisa Gastaldello, Chiara Gerardi et al. · 2024 · Frontiers in Public Health
  95. Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies
    Francis Ayimbila, Kamonrat Phopin, Waralee Ruankham, Ratchanok Pingaew, Supaluk Prachayasittikul, Virapong Prachayasittikul, Tanawut Tantimongcolwat · 2024 · European Journal of Pharmaceutical Sciences
  96. (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer
    Gloria Ana, Azizah M. Malebari, Sara Noorani, Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, Elisângela Flávia Pimentel, Denise Coutinho Endringer, Mary Jane Meegan · 2025 · Pharmaceuticals
  97. The importance of preclinical models for cholangiocarcinoma drug discovery
    Felix J. Krendl, Florian Primavesi, Rupert Oberhuber, Daniel Neureiter, Matthias Ocker, Dino Bekric, Tobias Kiesslich, Christian Mayr · 2025 · Expert Opinion on Drug Discovery
  98. Compound screening in human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies
    Yuki Ishii, Jessica C. Orr, Marie-Belle El Mdawar, Denise Regina Bairros de Pilger, David R. Pearce, Kyren A. Lazarus, Rebecca E. Graham, Marko Nikolić, Robin Ketteler, Neil O. Carragher et al. · 2025 · Journal of Cell Science
  99. Framework to identify innovative sources of value creation from platform technologies
    Charles H. Jones, Marie Beitelshees, Andrew Hill, Dean Griffiths, Matthew Murphy, Ketan Kapadia, Mikael Dolsten, Jane M. True · 2025 · Proceedings of the National Academy of Sciences
  100. Current advancement in AI-integrated drug discovery: Methods and applications
    Yash Mathur, Arunabh Choudhury, Sneh Prabha, Mohammad Umar Saeed, Md Nayab Sulaimani, Taj Mohammad, Md. Imtaiyaz Hassan · 2025 · Biotechnology Advances